Standard Biotools Inc. (LAB) at a glance

Standard Biotools Inc. (LAB) is a micro-cap Healthcare company. It trades at $0.64, with a 100.4% profit margin and revenue decline of 7.6%. It does not pay a dividend. Vestovix scores it 44/100 overall. Its strongest dimension is Value (73/100) and its weakest is Momentum (13/100). It carries above-market volatility, so expect larger swings.

Price

$0.64

Market cap

$255.2M

P/E ratio

n/a

Dividend yield

None

Beta

1.40

52-week range

$0.63 to $1.72